Pliant Therapeutics
$1.1400
68
-$0.02-1.72% 19:15 Today
Statistics
Day High
1.17
Day Low
1.14
52W High
1.95
52W Low
1.02
Volume
232,881
Avg. Volume
486,420
Mkt Cap
70.59M
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
5NovExpected
Q4 2024
Q1 2025
Q2 2025
Q3 2025
Q1 2026
Q2 2026
Next
-0.96
-0.74
-0.53
-0.32
Expected EPS
-0.380254
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-149.34MNet Income
Analyst Ratings
3.00Average Price Target
The highest estimate is 3.00.
From 2 ratings within the last 6 months. This is not an investment recommendation.
From 2 ratings within the last 6 months. This is not an investment recommendation.
Buy 50%
Hold 50%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow PLRX. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Madrigal Pharmaceuticals
MDGL
Mkt Cap12.33B
Gilead Sciences
GILD
Mkt Cap180.64B
Vertex Pharmaceuticals
VRTX
Mkt Cap137.3B
Incyte
INCY
Mkt Cap25.21B
Abbvie
ABBV
Mkt Cap451.46B
About
Pliant Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the discovery and development of integrin-based therapies. The company operates as a single reportable segment focused on developing and commercializing novel integrin-based treatments. Its lead product candidate, PLN-101095, is an oral small molecule targeting integrins for the treatment of solid tumors. The company also advances a pipeline of integrin-based programs across multiple disease areas through its proprietary drug discovery platform.
Show more...
CEO
Bernard Coulie
Employees
49
Country
United States
ISIN
US7291391057
WKN
000A2P4YV
Listings
0 Comments
Share your thoughts
FAQ
What is Pliant Therapeutics stock price today?▼
The current price of PLRX is $1.14 USD — it has decreased by -1.72% in the past 24 hours. Watch Pliant Therapeutics stock price performance more closely on the chart.
What is Pliant Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on XNAS exchange Pliant Therapeutics stocks are traded under the ticker PLRX.
Is Pliant Therapeutics stock price growing?▼
PLRX stock has fallen by -0.43% compared to the previous week, the month change is a +10.1% rise, over the last year Pliant Therapeutics has showed a -33.04% decrease.
What is Pliant Therapeutics market cap?▼
Today Pliant Therapeutics has the market capitalization of 70.59M
When is the next Pliant Therapeutics earnings date?▼
Pliant Therapeutics is going to release the next earnings report on November 05, 2026.
What were Pliant Therapeutics earnings last quarter?▼
PLRX earnings for the last quarter are -0.36 USD per share, whereas the estimation was -0.34 USD resulting in a -5.33% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Pliant Therapeutics revenue for the last year?▼
Pliant Therapeutics revenue for the last year amounts to 0 USD.
What is Pliant Therapeutics net income for the last year?▼
PLRX net income for the last year is -149.34M USD.
How many employees does Pliant Therapeutics have?▼
As of September 03, 2026, the company has 49 employees.
In which sector is Pliant Therapeutics located?▼
Pliant Therapeutics operates in the Health & Wellness sector.
When did Pliant Therapeutics complete a stock split?▼
Pliant Therapeutics has not had any recent stock splits.
Where is Pliant Therapeutics headquartered?▼
Pliant Therapeutics is headquartered in SOUTH SAN FRANCISCO, United States.